CoQ10 Reduces Heart Failure Deaths

Coenzyme Q10 is a vitamin-like compound, found in abundant levels in the mitochondria of cells as it is a substance vital to energy production. Svend Aage  Mortensen, from Copenhagen University Hospital (Denmark), and colleagues administered oral Coenzyme Q10 (100 mg, three times a day), or placebo, to 420 European and Asian subjects and followed them for a two-year period. At the end of the study term, 25% of the patients in the placebo group experienced a major adverse cardiovascular events, as compared to 14% in the group receiving CoQ10.  Further, mortality and hospitalizations were lower in the supplemented group: 18 patients died in the CoQ10 group, as compared to 36 in the placebo group. The researchers observed that CoQ10 reduce the levels ofNT-proBNP, a heart failure biomarker.